Health3-2-1 project opens doors to UK and US HealthTech markets

Is your company developing health technology, medical technology, or life sciences solutions and looking to expand into the UK or US markets?

The Interreg project Health3-2-1 supports small and medium-sized enterprises (SMEs) in the life sciences sector operating in Estonia, Finland, and Sweden, with up to €20,000 in tailored assistance for entering export markets – United Kingdom and the East Coast of the USA. The program offers personalized mentorship, business development support, connections in target markets, and the opportunity to join international business missions. Health3-2-1 runs until April 2027.

Upcoming 2026 Missions:

• UK Business Mission – London & Cambridge (14–18 September)
  The mission combines meetings and activities in London with participation in Cambridge Tech Week, one of the UK’s leading innovation and technology events.
• US Business Mission – Boston (18–21 October)
  Participants will join The MedTech Conference, the world’s leading medical technology event.

Apply and take your company to the next growth level:

• Interested in the UK mission to London and Cambridge? Express your interest here.
• Interested in the US mission to Boston? Express your interest here.

Health3-2-1 is an Interreg project implemented by Tehnopol, Business Turku, and Swecare, designed to help health technology companies achieve active market entry in the UK and US.